Comparison of Treatment Response and Survival Profiles Between Drug-Eluting Bead Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Chinese Hepatocellular Carcinoma Patients: A Prospective Cohort Study.

In conclusion, we found that DEB-TACE achieved higher treatment response and prolonged survival compared with cTACE in Chinese HCC patients. PMID: 31053181 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31053181?dopt=Abstract

Source: Oncology Research - May 6, 2019 Category: Cancer & Oncology Tags: Oncol Res Source Type: research